Align Financial’s Revolution Medicines RVMD Stock Holding History

Align Financial’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$616	Buy	+3	New	+$595	﹤0.01%	451

Other funds holding RVMD

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Loftus Peak Pty Ltd Sydney, Australia $781M AUM

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Align Financial's RVMD Position: Q3 2026 in Review

Align Financial opened a new position in Revolution Medicines (RVMD) in Q3 2026: 3 shares worth $616. The stake represents ﹤0.01% of the portfolio and ranks #451 among its holdings.

111 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Align Financial held 3 shares of Revolution Medicines worth $616 as of Q3 2026.
Revolution Medicines was a new Align Financial position in Q3 2026.
Revolution Medicines made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #451 holding.
111 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.